Prollenium Medical Technologies Inc.

Prollenium Medical Technologies Inc. is a Canadian-based, aesthetic medical device company located just north of Toronto, Ontario. Prollenium is the only manufacturer of HA dermal fillers in North America and is among a very select few companies to receive US FDA approval. Prollenium’s main focus is on the research, production, marketing and sales of biomaterials designed to treat the aging process and to enhance and maintain beauty.“Our main focus is to address all our clients’ needs through the production of innovative aesthetics products. A substantial share of our sales revenue is continually invested into the research and development of high quality materials to create a steady stream of new, exciting and superior products that deliver novel applications and offer outstanding benefits. We are very proud that this commitment has enabled us to provide a continuous pipeline of products that keeps us forward-looking and on the cutting edge.”By perennially investing a significant amount of its capital into the research and development of high quality materials, Prollenium is able to ensure a continual flow of value creation, unique ideas, and a steady pipeline of new and exciting products into the aesthetics marketplace. This investment allows Prollenium to be the expert in the research and production of HA dermal fillers, and to create products that provide safe and effective results. This commitment and expertise is the result of an enduring dedication to not only scientific advancement, but also a desire to play a prominent role in the progression of and innovation in the aesthetics industry.